The agreement, which also includes a team of biotech executives, will see Bluebird Bio’s stockholders receive $3.00 per share ...

Bluebird Bio (BLUE) announced that it has entered into a definitive agreement to be acquired by funds managed by Carlyle (CG) and SK Capital ...

JMP Securities analyst Brian McKenna maintained a Buy rating on Blue Owl Capital (OBDC – Research Report) today and set a price target of ...

Inc. (NASDAQ: BLUE) ("bluebird") today announced that it has entered into a definitive agreement to be acquired by funds managed by global investment firms Carlyle (NASDAQ: CG) and SK Capital Partners ...

James McDonald stole up to $3 million from clients and was hunted down by police after nearly three years as a fugitive.

James Arthur McDonald Jr., formerly of Arcadia, California, agreed to plead guilty to one count of securities fraud in connection to a scheme that cost his victims between $2.8 million and $3 million, ...

Watching the sun slowly set in Wadi Rum, the craggy desertscape takes on a whole new wonder. The red rocks glow golden for a moment, bathed in the final rays of the day, and the wind gently swirls the ...

James McDonald raised millions of dollars from investors that he used for personal expenses and Ponzi-like payments.

Bluebird Bio has commercialized three gene therapy products, including one of the first for sickle cell disease, but would soon run out of cash.